Literature DB >> 21937912

Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease.

Kunikazu Tanji1, Fumiaki Mori, Katsumi Kito, Akiyoshi Kakita, Junsei Mimura, Ken Itoh, Hitoshi Takahashi, Tetsu Kamitani, Koichi Wakabayashi.   

Abstract

α-Synuclein is a major component of Lewy bodies in Parkinson disease (PD) and dementia with Lewy bodies (DLB). We recently showed that abnormal α-synuclein with resistance to proteinase K (PK) is deposited at presynapses of distinct brain anatomic regions from the early stages of PD and DLB. NUB1, a synphilin-1-binding protein, also accumulates in Lewy bodies, but it is not known whether abnormal α-synuclein is associated with NUB1. Here, we demonstrate that, in the brain of patients with PD and DLB, NUB1 accumulates in the presynapses in the hippocampus, cerebral neocortex, and substantia nigra in which PK-resistant α-synuclein is deposited. Endogenous NUB1 also accumulated with PK-resistant α-synuclein in the presynapses of transgenic mice that express human α-synuclein with an A53T mutation. Immunoelectron microscopy showed that NUB1 is localized to presynaptic nerve terminals where no abnormal filaments are seen. Biochemical analyses showed that NUB1 coexists with abnormal α-synuclein in the brain of DLB patients. These findings suggest that NUB1 along with abnormal α-synuclein is involved in the pathogenesis of Lewy body disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937912      PMCID: PMC3181070          DOI: 10.1097/NEN.0b013e3182303745

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  41 in total

1.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

2.  The rat brain synucleins; family of proteins transiently associated with neuronal membrane.

Authors:  L Maroteaux; R H Scheller
Journal:  Brain Res Mol Brain Res       Date:  1991-10

3.  Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43.

Authors:  Hai-Xin Zhang; Kunikazu Tanji; Fumiaki Mori; Koichi Wakabayashi
Journal:  Neurosci Lett       Date:  2008-02-02       Impact factor: 3.046

4.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

Authors:  J M George; H Jin; W S Woods; D F Clayton
Journal:  Neuron       Date:  1995-08       Impact factor: 17.173

5.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

6.  Familial Parkinson's disease. The awakening of alpha-synuclein.

Authors:  M Goedert
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

7.  Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

Authors:  M Hashimoto; L J Hsu; Y Xia; A Takeda; A Sisk; M Sundsmo; E Masliah
Journal:  Neuroreport       Date:  1999-03-17       Impact factor: 1.837

8.  Purification and structural studies of a major scrapie prion protein.

Authors:  S B Prusiner; D F Groth; D C Bolton; S B Kent; L E Hood
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

9.  Synphilin-1 is present in Lewy bodies in Parkinson's disease.

Authors:  K Wakabayashi; S Engelender; M Yoshimoto; S Tsuji; C A Ross; H Takahashi
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

10.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Authors:  C F Lippa; H Fujiwara; D M Mann; B Giasson; M Baba; M L Schmidt; L E Nee; B O'Connell; D A Pollen; P St George-Hyslop; B Ghetti; D Nochlin; T D Bird; N J Cairns; V M Lee; T Iwatsubo; J Q Trojanowski
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more
  6 in total

Review 1.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

2.  NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.

Authors:  Shuai Liu; Hui Yang; Jian Zhao; Yu-Hang Zhang; Ai-Xin Song; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

3.  Ubiquitin-Modulated Phase Separation of Shuttle Proteins: Does Condensate Formation Promote Protein Degradation?

Authors:  Thuy P Dao; Carlos A Castañeda
Journal:  Bioessays       Date:  2020-09-03       Impact factor: 4.345

4.  Role of Ser129 phosphorylation of α-synuclein in melanoma cells.

Authors:  Byung Rho Lee; Yasuhiro Matsuo; Anil G Cashikar; Tetsu Kamitani
Journal:  J Cell Sci       Date:  2012-11-30       Impact factor: 5.285

Review 5.  Neddylation and deneddylation in cardiac biology.

Authors:  Sridhar Kandala; Il-Man Kim; Huabo Su
Journal:  Am J Cardiovasc Dis       Date:  2014-12-29

6.  Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.

Authors:  Raquel Pinho; Leonor C Guedes; Lilach Soreq; Patrícia P Lobo; Tiago Mestre; Miguel Coelho; Mário M Rosa; Nilza Gonçalves; Pauline Wales; Tiago Mendes; Ellen Gerhardt; Christiane Fahlbusch; Vincenzo Bonifati; Michael Bonin; Gabriel Miltenberger-Miltényi; Fran Borovecki; Hermona Soreq; Joaquim J Ferreira; Tiago F Outeiro
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.